Key Moments

286‒Journal club with Andrew Huberman: light exposure on mental health & an immunotherapy for cancer

Peter Attia MDPeter Attia MD
Science & Technology5 min read177 min video
Jan 22, 2024|45,980 views|882|70
Save to Pod
TL;DR

Optimizing light exposure (daylight/darkness) positively impacts mental health; immunotherapy offers hope for cancer treatment.

Key Insights

1

Exposure to bright daylight and minimizing nighttime light significantly improves mental health, reducing risks of depression, anxiety, PTSD, self-harm, and psychosis.

2

Specific light cues at dawn and dusk, involving the comparison of blue and orange/red wavelengths by specialized retinal cells, are crucial for regulating circadian rhythms and mood.

3

Immune checkpoint inhibitors (like anti-CTLA-4 and anti-PD-1) represent a significant breakthrough in cancer treatment, particularly for highly mutated cancers like melanoma, by unleashing the body's own immune system to fight tumors.

4

While checkpoint inhibitors can extend median and overall survival, especially for aggressive metastatic cancers, they often induce autoimmune side effects.

5

Reverse causality exists in mental health studies, where conditions like depression can alter light exposure patterns; however, the direct causal link of light to mental well-being is strongly supported by biological plausibility and dose-response effects.

6

Cancer's ability to evade the immune system often involves creating an acidic microenvironment and secreting immunosuppressive factors, highlighting the complexity of harnessing immunity against tumors.

THE PROFOUND INFLUENCE OF LIGHT ON MENTAL HEALTH

Light exposure demonstrably impacts mental health, as evidenced by seasonal affective disorder and studies involving over 85,000 individuals. Bright light exposure, particularly in the morning, and sufficient darkness at night are critical. This connection is deeply rooted in biological mechanisms involving intrinsically photosensitive retinal ganglion cells, which directly communicate with the brain's circadian clock and mood-regulating centers. These cells respond to both the intensity and specific wavelengths of light, influencing neurotransmitter release like dopamine and serotonin.

OPTIMAL LIGHT EXPOSURE FOR CIRCADIAN RHYTHM AND MOOD

For optimal health, four types of light stimuli are crucial: low solar angle sunlight at sunrise and sunset, and bright light exposure throughout the day, while minimizing light at night. Specialized retinal cells compare blue (short wavelength) and orange/red (long wavelength) light, which are uniquely abundant at dawn and dusk, to either 'phase advance' (morning light, promoting earlier sleep/wake) or 'phase delay' (evening light, promoting later sleep/wake) the circadian clock. Midday sun, though bright, is in the 'circadian dead zone' and primarily affects mood, not clock shifting.

CLINICAL EVIDENCE: DAY AND NIGHT LIGHT IMPACT ON PSYCHIATRIC DISORDERS

A large UK Biobank study found a significant association between day and night light exposure and psychiatric disorders. While the title was initially misleading, the conclusion was that greater daytime light and nighttime darkness reduce the risk of psychiatric conditions like major depressive disorder, generalized anxiety, PTSD, bipolar disorder, self-harm, and psychosis. The study used wrist-worn accelerometers to measure ambient light and correlated these patterns with diagnosed psychiatric outcomes, controlling for various confounding factors like age, sex, and activity levels. This indicates light as a potent, non-pharmacological means for improving mental health.

MELANOPSIN, LUX LEVELS, AND PRACTICAL RECOMMENDATIONS

The melanopsin-containing cells in the retina sum photons over time. Outdoor light, even on cloudy days, provides significantly more lux (up to 100,000) than brightly lit indoor environments (around 4,000-6,000 lux). Windows often filter out relevant wavelengths. Practical advice includes getting 10 minutes of morning sunlight without sunglasses, avoiding sunglasses during early/late day unless necessary, and minimizing artificial light at night. Even brief nighttime light exposure can disrupt melatonin, but the circadian clock is less affected during the 'circadian dead zones' of midday and midnight. Some individuals are more resilient or susceptible to these light effects.

CANCER IMMUNOTHERAPY: UNLEASHING THE IMMUNE SYSTEM

Cancer immunotherapy, particularly immune checkpoint inhibitors, represents a major advancement in oncology. The human immune system is designed to recognize and eliminate foreign pathogens without attacking itself, a process vital for health. However, cancer cells cleverly evade this, often by secreting immunosuppressive factors and creating an acidic microenvironment. The breakthrough came from recognizing that cancers often express antigens that the immune system can recognize, but the immune response is 'braked' by checkpoint molecules like CTLA-4 and PD-1 on T-cells.

CLINICAL TRIAL FINDINGS: ANTI-CTLA-4 FOR MELANOMA

A landmark phase III clinical trial investigated an anti-CTLA-4 drug (ipilimumab) for metastatic melanoma. This study compared ipilimumab, ipilimumab plus a non-efficacious cancer vaccine (GP100), and GP100 alone. Patients had very aggressive, treatment-resistant cancers. The study found that ipilimumab extended median survival by four months (from 6 to 10 months) and improved overall survival, with about 20% of patients still alive at 56 months compared to almost none in the control group. This demonstrated the power of 'taking the brakes off' the immune system.

TREATMENT SIDE EFFECTS AND CONSIDERATIONS FOR IMMUNOTHERAPY

Immune checkpoint inhibitors, while effective, can induce significant autoimmune side effects, affecting various body systems (e.g., gastrointestinal, skin). The trial's adverse event analysis showed a higher incidence of immune-related adverse events in the active treatment arms. This underscores the need for careful management, often requiring corticosteroids to suppress the overactive immune response. The efficacy of these drugs can vary by sex, potentially due to differences in immune response or dosing based on weight.

THE BIOLOGY BEHIND IMMUNOTHERAPY SUCCESS

Melanoma was an early target for immunotherapy because it often has many genetic mutations, increasing the likelihood of producing foreign antigens that the immune system can detect. The success of checkpoint inhibitors against cancers with a high mutational load, like certain pancreatic cancers in individuals with Lynch syndrome, highlights the principle of providing 'more shots on goal' for T-cells. The ultimate goal in cancer immunology is to engineer T-cells to be better at recognizing and eliminating cancer cells, bridging the gap between their 'wisdom' (recognition) and 'youth' (killing capacity).

REVERSE CAUSALITY AND DOSE-RESPONSE IN EPIDEMIOLOGY

The discussion often touched upon reverse causality in observational studies, where an existing condition (e.g., depression) might influence light exposure patterns rather than light exposure solely causing the condition. However, the biological plausibility, strong associations, and clear dose-response relationships (e.g., increased light exposure leading to progressively better outcomes, or vice versa) in the light-mental health studies strongly support a causal link. This aligns with Bradford Hill's criteria for inferring causality in epidemiological research, suggesting meaningful actionable insights despite inherent complexities.

FUTURE DIRECTIONS FOR CANCER AND HEALTH

The overall vision for cancer treatment is to continue harnessing and optimizing the immune system, including approaches like engineered T-cells. For general health, maintaining a robust immune system through healthy lifestyle choices, including proper light exposure and sleep, is crucial, especially given the age-related decline in immune function. The debate also touched on the critical distinction between genetic (mutations) and inherited (germline mutations) cancer predispositions, and the importance of preventing sunburn rather than just sun exposure for reducing melanoma risk, while also acknowledging the complex role some sunscreens might play.

Common Questions

Recent studies in over 85,000 people suggest a powerful and independent role of both daytime light exposure and nighttime dark exposure for mental health, impacting mood, sleep, and psychiatric disorders such as depression, anxiety, PTSD, and bipolar disorder.

Topics

Mentioned in this video

bookNature Mental Health

A new journal where the discussed paper 'Day and Night Light Exposure are Associated with Psychiatric Disorders and Objective Light Studies in More than 85,000 People' was published.

personSamar Hatar

Head of the Chronobiology Unit at the National Institutes of Mental Health, known for extreme measures to avoid light exposure at night.

toolaccelerometers

Wrist-worn devices used in the study to measure ambient light and activity, though not perfect at eye-level light measurement.

conceptCTLA-4

A receptor on T-cells that acts as a 'brake' on the immune system, preventing an overactive response; blocking it is a strategy in immunotherapy to unleash the immune system against cancer.

productsunglasses

Eyewear that filters out light, recommended for midday sun but cautioned against during early morning and late afternoon light exposure for circadian rhythm regulation.

productSAD lamps

Bright lights, typically 10,000 Lux or more, used to treat Seasonal Affective Disorder, often placed on kitchen counters or office desks.

conceptCD8 T-cells

Also known as killer T-cells, these immune cells recognize and target foreign proteins presented by MHC class 1 receptors, replicating and proliferating to mount an immune response.

drugIpilimumab (Yervoy)

The first anti-CTLA-4 drug discussed, shown to extend median survival in metastatic melanoma.

conceptmelanopsin retinal ganglion cells

Intrinsically photosensitive cells in the retina that respond to two types of light input, sending signals to the hypothalamus to set the circadian clock and influencing mood through connections to other brain structures.

conceptSeasonal Affective Disorder (SAD)

A type of depression that's related to changes in seasons, with symptoms typically beginning in the fall and continuing into the winter months.

personAli Crum

Mentioned for discussing the psychological impact of sleep trackers and how poor scores can negatively affect perceived well-being.

conceptthymic selection

A process occurring in infancy in the thymus where T-cells are 'educated' to recognize self, with any T-cells that fail to recognize self being eliminated.

personMatt Vander Heiden

Co-author of a very influential paper in 2009 proposing that the Warburg effect in cancer cells optimizes for cellular building blocks rather than energy.

conceptPD-1

Another checkpoint protein on T-cells, similar to CTLA-4, that inhibits immune response; drugs targeting PD-1 (like Keytruda) are also a form of checkpoint inhibitor.

organizationChuck Czeisler Lab

A phenomenal lab at Harvard Medical School exploring circadian human health behavior, considered a luminary in the field; once published an erroneous-but-retracted study on light behind the knee shifting circadian rhythms.

softwareLight meter app

A free mobile application that measures lux levels in an environment.

productCGM (Continuous Glucose Monitor)

A device that continuously tracks glucose levels, described as a behavioral tool for insight into how inputs affect outputs, similar to sleep trackers.

personLuke Cantley

Co-author of a very influential paper in 2009 proposing that the Warburg effect in cancer cells optimizes for cellular building blocks rather than energy.

personDavid Berson

Researcher at Brown University who performed historic experiments recording from intrinsically photosensitive cells.

organizationStanford Sleep Lab

A research institution whose studies indicate that checking the time in the middle of the night can disrupt sleep and perceived energy levels the next day.

drugInterleukin-2 (IL-2)

A cytokine that acts as 'candy and fuel' for T-cells, used in early immunotherapy to promote T-cell proliferation but only effective in a small percentage of melanoma and kidney cancer patients.

drugKeytruda

An anti-PD-1 drug that emerged shortly after Ipilimumab, shown to be even more effective in treating metastatic melanoma with a greater response rate.

toolWhipple procedure

A complex surgical procedure to remove the head of the pancreas, often used for pancreatic cancer, but patients can still recur if micro-metastases are present.

More from Peter Attia MD

View all 108 summaries

Found this useful? Build your knowledge library

Get AI-powered summaries of any YouTube video, podcast, or article in seconds. Save them to your personal pods and access them anytime.

Try Summify free